BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro (

Font size: Decrease font Enlarge font

Mon, 10 Feb 2014 16:41:32 GMT – Feb 10 (Reuters) – Vectura Group PLC : * Norwegian regulatory authority confirm approval of airflusal forspiro * Treatment is new inhaler for patients with asthma and chronic obstructive

Full Story BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro

Tags: , , , , ,

Add to:

More Health News
BRIEF-Rhoen Klinikum says reached settlement of law suits » (

Mon, 29 Sep 2014 18:11:58 GMT – Sept 29 (Reuters) – Rhoen-Klinikum : * Says reached settlement of law suits against resolutions of the annual

BRIEF-World Intellectual Property Office publishes 3 new Oncodesign patents » (

Mon, 29 Sep 2014 17:17:23 GMT – * Says its scientists co-authored scientific paper in Journal Of Biological Chemistry highlighting RIP2 inhibitors in inflammatory disease

Founder sells 5 mln shares in Al Noor Hospitals Group » (

Mon, 29 Sep 2014 16:03:19 GMT – LONDON, Sept 29 (Reuters) – Maksar Investments is to sell 5 million existing shares in Al Noor Hospitals Group on behalf of the UAE healthcare company’s founder Kassem Alom, in an accelerated offering run by Goldman Sachs, the bank said on Monday.

TRF-Rains complicate delivery of Ebola supplies in West Africa » (

Mon, 29 Sep 2014 16:50:39 GMT – WASHINGTON, Sept 29 (Thomson Reuters Foundation) – The rainy season in West Africa is compounding difficulties in getting supplies delivered and new treatment centres built as donors rush to isolate people infected with the deadly Ebola virus and stop its rapid spread, U.S. officials said.

Well: Working Long Hours Tied to Diabetes Risk » (

Mon, 29 Sep 2014 20:15:09 GMT – Working long hours may increase the risk for Type 2 diabetes, a new review has found, but the risk is only apparent in workers of lower socioeconomic status.

Q&a: Rating Pain Relief » (

Mon, 29 Sep 2014 20:39:35 GMT – How is the effectiveness of pain relievers measured? Is there a list that quantifies them by strength?

Well: Celiac Disease, a Common, but Elusive, Diagnosis » (

Mon, 29 Sep 2014 14:52:51 GMT – A main reason for a lag in the detection of celiac disease is the long and confusing list of signs and symptoms, some of which may be mild enough to be easily ignored or attributed to another condition.

The New Health Care: Auto-Renewing Your Health Plan May Be Bad for You, and for Competition » (

Mon, 29 Sep 2014 14:01:13 GMT – People hate to shop around, particularly for things as complicated as health insurance. But that may open the door to bigger rate increases.

BrainStorm shares to be listed on Nasdaq Capital Market » (

Mon, 29 Sep 2014 12:19:13 GMT – TEL AVIV, Sept 29 (Reuters) – BrainStorm Cell Therapeutics Inc., an Israeli developer of adult stem cell treatments for neurodegenerative diseases, said its stock has been approved for listing on the Nasdaq Capital Market.

UPDATE 1-Seattle Genetics and Takeda's cancer drug meets main trial goal » (

Mon, 29 Sep 2014 12:53:38 GMT – Sept 29 (Reuters) – Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer.